" • In current Phase 1b breast cancer trial for PTX-200, interim
analysis showed encouraging efficacy (including biomarker data)."
Encouraging interim disclosure, in a professional presentation.
- Forums
- ASX - By Stock
- PTX
- Ann: Rodman & Renshaw Global Investment conference Presentation-PTX.AX
Ann: Rodman & Renshaw Global Investment conference Presentation-PTX.AX, page-2
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.8¢ |
Change
-0.001(2.56%) |
Mkt cap ! $30.60M |
Open | High | Low | Value | Volume |
3.9¢ | 3.9¢ | 3.8¢ | $47.91K | 1.256M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 881755 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.9¢ | 150000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 802755 | 0.038 |
5 | 393000 | 0.037 |
8 | 688946 | 0.036 |
7 | 500304 | 0.035 |
2 | 140000 | 0.034 |
Price($) | Vol. | No. |
---|---|---|
0.039 | 150000 | 2 |
0.040 | 200000 | 2 |
0.041 | 66157 | 1 |
0.042 | 180000 | 2 |
0.043 | 200000 | 1 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online